Pulmatrix (NASDAQ:PULM) Share Price Crosses Above 50 Day Moving Average – Time to Sell?

Pulmatrix, Inc. (NASDAQ:PULM)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $6.15 and traded as high as $6.20. Pulmatrix shares last traded at $5.98, with a volume of 19,433 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Pulmatrix in a research report on Sunday, January 5th. They set a “hold” rating on the stock.

Pulmatrix Stock Performance

The business has a fifty day moving average of $6.15 and a two-hundred day moving average of $3.52. The firm has a market capitalization of $21.83 million, a price-to-earnings ratio of -2.27 and a beta of 1.52.

Pulmatrix (NASDAQ:PULM) last issued its quarterly earnings data on Friday, November 8th. The biotechnology company reported ($0.71) earnings per share for the quarter. The company had revenue of $0.37 million during the quarter. Pulmatrix had a negative net margin of 96.51% and a negative return on equity of 45.97%.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.